EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 9th, 2018 • Immunomedics Inc • In vitro & in vivo diagnostic substances • New Jersey
THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of the 27th day of March, 2018 (the “Effective Date”) by and between Immunomedics, Inc., a Delaware corporation having its principal offices in Morris Plains, New Jersey (the “Company”) and Robert Iannone (the “Executive”).
IMMUNOMEDICS, INC. COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • May 9th, 2018 • Immunomedics Inc • In vitro & in vivo diagnostic substances • New York
THIS COMMON STOCK PURCHASE AGREEMENT (the “Agreement”) is made as of January 7, 2018 (the “Execution Date”) by and between Immunomedics, Inc., a Delaware corporation (the “Company”), and RPI Finance Trust, a Delaware statutory trust (the “Investor”).
FUNDING AGREEMENT BY AND BETWEEN IMMUNOMEDICS, INC. AND RPI FINANCE TRUST DATED AS OF JANUARY 7, 2018Confidential Treatment • May 9th, 2018 • Immunomedics Inc • In vitro & in vivo diagnostic substances • New York
This FUNDING AGREEMENT, dated as of January 7, 2018 (this “Agreement”), is made and entered into by and between RPI FINANCE TRUST, a Delaware statutory trust (the “Buyer”), and IMMUNOMEDICS, INC., a Delaware corporation (the “Seller”).
